QS Investors’s Core Laboratories CLB Stock Holding History

QS Investors’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-26	Closed	-$2K	–	1679
2018 Q4	$2K	Hold	26	–	–	﹤0.01%	1639
2018 Q3	$3K	Hold	26	–	–	﹤0.01%	1638
2018 Q2	$3K	Buy	26 +13	+100%	+$1.58K	﹤0.01%	1661
2018 Q1	$1K	Hold	13	–	–	﹤0.01%	1740
2017 Q4	$1K	Hold	13	–	–	﹤0.01%	1749
2017 Q3	$1K	Sell	13 -800	-98%	-$77.5K	﹤0.01%	1717
2017 Q2	$82K	Buy	813 +7	+0.9%	+$755	﹤0.01%	1421
2017 Q1	$93K	Buy	806 +800	+13,333%	+$93K	﹤0.01%	1402
2016 Q4	$1K	Hold	6	–	–	﹤0.01%	1562
2016 Q3	$1K	Hold	6	–	–	﹤0.01%	1547
2016 Q2	$1K	Hold	6	–	–	﹤0.01%	1574
2016 Q1	$1K	Hold	6	–	–	﹤0.01%	1564
2015 Q4	$1K	Buy	+6	New	+$687	﹤0.01%	1582
2015 Q1	–	Sell	-7,600	Closed	-$915K	–	1393
2014 Q4	$915K	Buy	+7,600	New	+$998K	0.01%	750

Other funds holding CLB

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

QS Investors's CLB Position: Q1 2019 in Review

QS Investors sold out of Core Laboratories (CLB) in Q1 2019, closing a stake of 26 shares — an estimated $2K sold.

QS Investors first reported a position in CLB in Q4 2014 and held it in 14 quarters. The position peaked at $915K in Q4 2014. 313 funds tracked by Wall St. Rank hold CLB as of Q1 2019.

QS Investors reported no remaining Core Laboratories position as of Q1 2019 after selling out during the quarter.
QS Investors sold 26 Core Laboratories shares in Q1 2019, an estimated $2K.
QS Investors first reported a position in Core Laboratories in Q4 2014 and held it in 14 quarters.
QS Investors's Core Laboratories position peaked at $915K in Q4 2014.
313 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2019.

Based on QS Investors's 13F filing for Q1 2019, filed 15 May 2019.